Ransomware victim disclosure
← All victimsFreyr Solutions
Claimed by Quantum · listed 4 years ago
Status timeline
- Listed
Aug 8, 2022
- Data leaked
At a glance
- Group
- Quantum
- Status
- Data leaked
- Country
- United States
- Sector
- Information Technology
- Listed on leak site
- Aug 8, 2022
About the victim
AI dossier — public-source company profileFreyr Solutions is a global regulatory-focused solutions and services company serving the Life Sciences industry, including pharmaceutical, medical device, biotechnology, and consumer healthcare sectors. The company supports clients across the full regulatory value chain, from regulatory strategy and intelligence to dossier preparation, submissions, labeling, and post-approval product maintenance. It serves large, medium, and small Life Sciences companies worldwide.
- Industry
- Regulatory Affairs & Compliance Services – Life Sciences
- Employees
- 1001-5000
Attack summary
Severity: critical — Freyr Solutions handles highly sensitive regulated data for pharmaceutical, medical device, and biotechnology clients globally. Exfiltration and publication of regulatory dossiers, submissions, and product data constitutes a critical breach of regulated/sensitive business and potentially patient-safety-related information affecting numerous Life Sciences companies worldwide.The Quantum ransomware group claims to have exfiltrated data from Freyr Solutions and has published the data. The disclosed status indicates data has been published, though specific file counts or data volumes were not stated in the post.
Data the group says was taken
AI dossier — extracted from the leak post- Regulatory strategy documents
- Regulatory dossiers and submissions
- Post-approval product maintenance records
- Labeling and artwork change management files
- Client Life Sciences company data
- Internal business documents
What the group claims
Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry supporting, Large, Medium, and Small size global Life sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics | Food and Food Supplements | Chemicals) in their entire Regulatory value-chain; ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post-approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions
Source
Indexed 4 years agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
